Cell Reports (Jun 2023)

Precise microdissection of gastric mixed adeno-neuroendocrine carcinoma dissects its genomic landscape and evolutionary clonal origins

  • Miao-Zhen Qiu,
  • Qingjian Chen,
  • Dan-Yang Zheng,
  • Qi Zhao,
  • Qi-Nian Wu,
  • Zhi-Wei Zhou,
  • Li-Qiong Yang,
  • Qiu-Yun Luo,
  • Yu-Ting Sun,
  • Ming-Yu Lai,
  • Sha-Sha Yuan,
  • Feng-Hua Wang,
  • Hui-Yan Luo,
  • Feng Wang,
  • Yu-Hong Li,
  • Hui-Zhong Zhang,
  • Rui-Hua Xu

Journal volume & issue
Vol. 42, no. 6
p. 112576

Abstract

Read online

Summary: Gastric mixed adenoneuroendocrine carcinoma (MANEC) is a clinically aggressive and heterogeneous tumor composed of adenocarcinoma (ACA) and neuroendocrine carcinoma (NEC). The genomic properties and evolutionary clonal origins of MANEC remain unclear. We conduct whole-exome and multiregional sequencing on 101 samples from 33 patients to elucidate their evolutionary paths. We identify four significantly mutated genes, TP53, RB1, APC, and CTNNB1. MANEC resembles chromosomal instability stomach adenocarcinoma in that whole-genome doubling in MANEC is predominant and occurs earlier than most copy-number losses. All tumors are of monoclonal origin, and NEC components show more aggressive genomic properties than their ACA counterparts. The phylogenetic trees show two tumor divergence patterns, including sequential and parallel divergence. Furthermore, ACA-to-NEC rather than NEC-to-ACA transition is confirmed by immunohistochemistry on 6 biomarkers in ACA- and NEC-dominant regions. These results provide insights into the clonal origin and tumor differentiation of MANEC.

Keywords